777 related articles for article (PubMed ID: 19688366)
1. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
2. Semiautomated versus manual evaluation of liver metastases treated by radiofrequency ablation.
Keil S; Bruners P; Ohnsorge L; Plumhans C; Behrendt FF; Stanzel S; Sühling M; Günther RW; Das M; Mahnken AH
J Vasc Interv Radiol; 2010 Feb; 21(2):245-51. PubMed ID: 20123208
[TBL] [Abstract][Full Text] [Related]
3. Dose reduction for semi-automated volumetry of hepatic metastasis in MDCT studies.
Keil S; Plumhans C; Nagy IA; Schiffl K; Soza G; Behrendt FF; Mahnken AH; Günther RW; Das M
Invest Radiol; 2010 Feb; 45(2):77-81. PubMed ID: 20027116
[TBL] [Abstract][Full Text] [Related]
4. Hepatic radiofrequency under CT-fluoroscopy guidance.
Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
7. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis.
Frich L; Hagen G; Brabrand K; Edwin B; Mathisen O; Aaløkken TM; Gladhaug IP
J Vasc Interv Radiol; 2007 Sep; 18(9):1134-40. PubMed ID: 17804776
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
[TBL] [Abstract][Full Text] [Related]
10. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis.
Berber E; Tsinberg M; Tellioglu G; Simpfendorfer CH; Siperstein AE
J Gastrointest Surg; 2008 Nov; 12(11):1967-72. PubMed ID: 18688683
[TBL] [Abstract][Full Text] [Related]
11. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
14. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
15. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
17. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
18. [Radiofrequency ablation of malignant liver tumors].
Nielsen DT; Laursen HB; Rokkjaer M; Astrup LB
Ugeskr Laeger; 2002 Sep; 164(40):4642-5. PubMed ID: 12380115
[TBL] [Abstract][Full Text] [Related]
19. Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results.
Mahnken AH; Klotz E; Schreiber S; Bruners P; Isfort P; Günther RW; Wildberger JE
AJR Am J Roentgenol; 2011 May; 196(5):W573-9. PubMed ID: 21512047
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.
Leblanc F; Fonck M; Brunet R; Becouarn Y; Mathoulin-Pélissier S; Evrard S
Eur J Surg Oncol; 2008 Feb; 34(2):185-90. PubMed ID: 17998155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]